Posted On: 11/16/2015 9:49 AM
UPWARD– A study of Xtandi in men with prostate cancer
1. Male age 18 or over
2. Meet PSA criteria
Sponsored by: Astellas
Length of Study: 1 year
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 7
Our Investigator for this study is Christopher Pieczonka, M.D.